BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹115 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹71 Cr |
| Mar2021 | ₹42 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 32.18 | |
| Mar2024 | ₹115 Cr | 35.48 | |
| Mar2023 | ₹85 Cr | 19.55 | |
| Mar2022 | ₹71 Cr | 67.68 | |
| Mar2021 | ₹42 Cr | - | |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹677.6 Cr | 18% | 12.7% | 206% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 18% |
12.7% |
206% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses